The use Bacillus cereus Phospholipase C in Prophylaxis and Treatment of Thromboplastin Induced Thrombosis in Mice


Bahrouz M. A. Al-Jaff, & Dlnya A. Mohammed

College of Education, University of Sulaimani, 2 College of Science, University of Sulaimani





Abstract
Volumes of crude cell free filtrate and steps of partial purified phospholipase C were prepared from non-toxigenic bacilhis cereus isolate. Also concentraions of highly purifed preparation (ICN) was used. Prophylaxis against greater than LD50 thrombopastin (0.0612mg/mouse) revealed recovery of mice with 97% 100% and 97% for cell free filtrate, haemolysin cured and sephadex cluted phospholipase C respectively with no significant differences among injection time intervals while the pure preparation recovered 97% mice with a significant differences among time intervals . Treatment by post thrombosis induction revealed that cell ree filtrate, partial purification steps and the highly purified phospholipase C recoverd 98% mice with no significant differneces among injection time intercals . The haematological parameters PCV, RBC count and platelet count remained within normal range after 12 hours of injection, These results suggested the possibility of using partially purified and highly purified phospholipase C as prophylactiv agent against infarction in man .

Keywords : B. cereus, thrombosis, thromboplastin, prophylaxis



Referenecs

l. Roberts. H. R. and Lozier, .J, N, new prospective on the coaguiation cascade. Hospital practise. 1992)27.97 .
2. Ale'ion. L. I'1. Neri' approacires tc maragement of bleeding disorders. Hospital Practice. 1999,21,207.
3. Esnout, h4. P. and Prowse, C. V. The gamma-carboxyglu'ramic acid content of hurnan
bovine prothrombin following warfaring treatment. Biacltim. Biophys. Acta. 1977,490, 471-476.
4. Esrnon, C.T. The regulation of natural anricoaguiation pathwavs.5cience1987,235,1348.
5. Schreiber, T. L. Aspirin and thrombolotyc therapy for acute myocardial infarction: should the combination norv be the routine iherapi'? Drugsl999, 38, 180.
6. Benedici, C. R.; Mueller, S.; AnCerson, H. V. and $iilierson, J. T. thrombolytic therapy: A state of the art revie.,v. Ilaspitai prcctice. 1992,27 , 5l ,
7. Coi:be, S. IvlThe last on throirbol'vsis? Streptckinase and aspirin sweep the field. Br. Med..
J. vtord 1992, 304,1454.
8. Emeis, J, J.; Verheijen J, H.; Ronday H. K.; de Maat M. P. M and Erakman P. Prr:gress in
clinical fibrinolysis. Fibrinolysis proteolysis l997 , 11, 67-84.
9. Loayza, S. L. T; Markland, F. S, and Riqueime, P. K. Resolution of isofornies of natural
and recombinant fibrolase, the fibrinolytic enzyrne fromAgkistroclon contrcrrix cantrorrix
snake venom, and cornparison of their EDT'A sensitivities ."1. chromatogr. B. Bionted Appl 1991, 662(2),227 -243.
10. Guan. Retzios A. L; Henderson A. D" and Markland, F. S. Purification and
characterization of a fibrinolytic enzyme fioin venorn of the southern copperhead snake
Agkistrodon controtrix contortrix. Arch. Biochem. Biophys. 1991, 8(2), 197 207 ,
I 1. Bijorklid, E. and Storm, E. Furificatioir and praperties of the protein component of tissue
thronrbopiastin fiom human brain. Biochem. J. 1977,165, 89.
12. Nenterson, Y, The phospholipids requirement of tissue factor in blood coagulation. The
j ourn al of cl in i cal Inve s ti gat ion. 1968,47 .
13. Giercksky, I(, E; Bjorklid, E.; Frudz, H. and Renck, F{.: Circulation tissue
thromboplastin during hip surgery, Eur. .L Surge. Resl979. Nl,296. ,4 --*tl>l ,3af .'a a-ft.:,;!f :t-:L..d:!t.",8t
14. Hitland, O. Johnsen B.; Janson T. L and Prydz H. Intravenous injection of tissue
thrornbolastin and phospholipase C in rabbits. Scand. J. Clin Lab. Invest 1983, 43, 35-40.
15. Giercksky, K, E; Bojorklid, E. and Prydz, H: The effect of intravenous injection of
purified human tissue thromboplastin in rats. Scand. J. Haematol. 1976, 16, 300.
16. Giercksky, K. E. and Bjorklid, E. protection of rats by phospholipase C from Bacillus
cereus against the effects of intravenous infusions of purified tissrie tlrromboplastin.
Scand. J. Hlemaiol. 1916, 17,305.
17. Nakagaki, T.; foster, D. C.; Berkner, K. L. and Kisiel, W. Initiation of the extrinsic
pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of
human coagulation factor VII. Biochemistry" 1991, 30, 108 i,
18. Neuenschwander, P. F.; Fiore, M. M, and ltrlorrissey, J. H. Factor VII auto activation
proceeds via interaction of distinct protease cofactor and zymogen-cofactor complexes.
Implification of two dimensional enzyme kinetic mechanism. J. Boil. chernl991. 268,
21489;
19. Little, C.; Aurebekk B. and Otnaess A. B. Purification by affinity clrromatography of
phosphoilpase C from Bacillus cercus. FEBS Lett. 1975,52,175-179.
20. Otnaess, A. B.; Little C.; walin K.; Johnsen R.; Flensgoud S. and Pryzdz H. Sorne
characteriz,ation of phospholipase C from Bacillus cereus. Eur. J. Biochem. 1917,79,459-
468.
21. Gilmore, M.S.; Cruz-Rodz A. L; Leimeister-wachter M; Kreft J. and. Goebbel W. A
Bacillus cereus cytoll.tic determinant, cereolysin AB, which comprises the phospholipase
C and sphingomyelinase genes; nucleotide seqrcnce and genetic linkage. J. Bacteriol .
1989, 171 ,744-',753. 22. Titball. W. Bacterial phospholipaseC. Microbiological Reviews1993.57 (2),347-366,
23. Titball, R. W.; Leslie L.; Harvey S. and. Kel1y D.C. Haemolytic and sphingomyelinase
activities af Clostridium perfringens alpha-toxin are dependent or a domain homologous
to that of an enzyme from the human arachidonic acid pathway. .Infect. lmmun. 1991 ,59,
1872-r874.
24. Wazny, T. K. and Stvrt. B. Degranulation of human neutrophills after exposure to
bacterial phospholipaseC. Eur, J. Clin. tuIicrabioi. lnfect. Dis.,1990, 1/,830.
25. Gollub, S.; Ottolenghi, A. C.; Rutmar, J. R.; Lisbinsk.v, L. and Uline, A.W.,
Thromboplastinase-an experimental antithrombotic, Thromb. Diath. Haem. 1962,7,470.
26. Otnaess, A. B.; Prydz, H.; Bjorklid, E. and Berre, A. Phosphlipase C from Bqcillus
cereus-and its use in studies of tissue thromboplastin. Eur. J. Biochem. 1972,27,238.
27. Kaplun, A.J.; Pry,Jz H and Allison A. C. Protection of pregnant mice with
phospholipase C and rvith arvin against foetal death induced by bacterial
Lipopoiyacchride.Br. J. Exp. Path. 1979,60, 185.
28. Hitland, O. Janson, T. L. and Johnson, B. In vitro effect of phospholipase C from
Bacillus cereus on tissue thromboplastin from dilferent species, Throm. Res. 1982,28,93.
29. Dalaker, A. and Prydz, H. The coagulation factor Vll in pregnany. Br. J. Hqematol.
1984,56,233.
30, Jansson, L G.; Hitland, O.; Rammer, L. M.; Predz, H. E. and Lennquist, S. E. Effect of
phospholipase C, a tissue thromboplastin inhibitor, on pulmonary microembolism after
missile injury of the lirnb. J Trauma.1988,28,Sz2z.
31. Mohammed, D and Al-jaff B. M. Isolation of non-toxigenic high lecithinase producing
Bacillus cereus. Kurd Acad.J. 2004,3A( 1),77-88.
32. Arribas, M. L.; Plaza, G. J.; Delarosu, M and Mosso, IvL A. Characterization of
Bacillus cereus strains isolated from drugs and evaluation of their toxins. J. Appl.
Bacteriol. 1988, 64, 251 -264.
33. Aessa, M. T. F" 1995 Study on Alpha Toxin of Clostridiutt perfringens Isolated from
Local Soil, A thesis submitted to the college of Science, University of Baghdad- Baghdad-
Iraq, in partial ful{illment of the Requirement for the degree of Master of Science in
34. Muhammed, S. M. 1998 Comparative sfudy of sonie physiological aspects in three
Bivalve species in Habania Lake. A thesis submitted to the coilege of science, University
of Anbar in partial fulfillment of the requirement for the degree of Master of Science in
biology.
35. Turnhull, P. C. B.; I(ramer, J. M.; Jongensen, K.; Gilbert, R. and Mellin, J. properties and
production c,haracteristics of vomiting, diarheal and necrotizing toxins of Bacillw,s eereus.
Ar.n. J. Clin. Nur. 1979, 32, 219 -228.
36. Rigby, G. J. An egg yolk agar diffusicn assay for monitoring phospholipase C in cultures
of Clostridium welchii, J. ,appl. Bqcteriol. 1981, 50, 1 1-19.
37, Sakurai, J.; Eujii, Y.; Torii, K. and Kobayashi, K. Dissociation of varios biological
actiyities of Closffidium perfringerus alpha toxin by chemical modification. Toxicon, 1989,
27 (3),317-323.
38. Saeed , K, H. iv{. and Habib, O .A M. 1990 Practical anirnal physiolctgy.Dar Al-Hekma
press, Mosel, Iraq. (In Arabic).
39. Bain. B. J. and Cavill, I. Hypochromic macrocytes-are they reticulo -cytes? J. Ctin.
P athol. 1993, 2, 38X -391.
40. Bain, B. J, Platelet count and platelet size in males and females. Scsnd. J. llaematol. 1985,
35. 77 .
41. Drobniewski, A. Bacillus cereus and related species. Clin. Microbial. Rev "Oct, 1993 a
324-338.
42. Granum, P. E. Bacillus cereus and its toxins. J. Appl. Bscteriol. Symp. Suppte.
1994,76,651-665.
43, Beec,her, D. J. and Macmillan J. D. Novel biocomponent haemolysin fram Bscillus cereus.
Infect. lmmttn. 199A, 58. 2220-2221 .
44. Vohverk, J, J.; Wether. P. B.: Evans, L. M. and Griffin, O. H. Phosphaiidylinositol-
specific phospholipase C irom Bacillus: improv-ed purification, amino acid composition,
and aminoterminal sequence. J. Cell. Bio-chem. 1989,39,315-32i.
45. otonaess, A. B.; Gierckskv, K. E. And Prydz, H. Parental administration of
phospholipase C in the rat. Distribution, elimination and lethal doses. Scand. J. Ctin. t ab.
Invest. 1976,36,553.
46. Little, C. B. and Otnaess A. B. Purification by atTinity chrornatography of phosphoilpase
C from Bscillus cercus. FEBS Lett. 1975, 52.175-179.